Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2012.05.009PMID 22853973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interocular symmetry in peripapillary retinal nerve fiber layer thickness measured with the Cirrus HD-OCT in healthy eyes.

  2011cited by this paper
• Retinal nerve fiber layer thickness in Vigabatrin‐exposed patients

  2011cited by this paper
• Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity

  2011cited by this paper
• Detecting Retinal Vigabatrin Toxicity in Patients with Partial Symptomatic or Cryptogenic Epilepsy

  2010cited by this paper
• Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy

  2010cited by this paper
• Effect of myopia on the thickness of the retinal nerve fiber layer measured by Cirrus HD optical coherence tomography.

  2010cited by this paper
• Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review

  2010cited by this paper
• Detecting retinal vigabatrin toxicity in patients with partial symptomatic or cryptogenic epilepsy.

  2010cited by this paper
• Visual fields at school‐age in children treated with vigabatrin in infancy

  2009cited by this paper
• Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin

  2009cited by this paper
• Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity.

  2009cited by this paper
• Retinal nerve fibre layer characteristics with vigabatrin-associated visual field loss—could scanning laser polarimetry aid diagnosis?

  2008cited by this paper
• Visual Field Severity Indices Demonstrate Dose‐Dependent Visual Loss from Vigabatrin Therapy

  2008cited by this paper
• A framework for comparing structural and functional measures of glaucomatous damage.

  2007cited by this paper
• Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.

  2006cited by this paper
• Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results.

  2006cited by this paper
• Visual field constriction associated with vigabatrin: retinal nerve fiber layer photographic correlation

  2004cited by this paper
• Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children.

  2004cited by this paper
• Characterization of vigabatrin-associated optic atrophy.

  2003cited by this paper
• The Effect on Vision of Associated Treatments in Patients Taking Vigabatrin: Carbamazepine Versus Valproate

  2002cited by this paper
• Visual field loss associated with vigabatrin: pathological correlations

  2001cited by this paper
• Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin

  2000cited by this paper
• Characteristics of a Unique Visual Field Defect Attributed to Vigabatrin

  1999cited by this paper
• Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

  1999cited by this paper
• The anatomical basis of the caecocentral scotoma. New observations and a review.

  1990cited by this paper
• Retinogeniculate projection fibers in the monkey optic nerve: A demonstration of the fiber pathways by retrograde axonal transport of WGA‐HRP

  1989cited by this paper
• The course of axons through the retina and optic nerve head.

  1979cited by this paper

• Machine-learning algorithms for the identification of visual field loss associated with the antiseizure medication vigabatrin—a proof of concept

  2025cites this paper
• Recent advances in the use of optical coherence tomography in neuro‐ophthalmology: A review

  2024cites this paper
• The thickness of the retinal nerve fiber layer, macula, and ganglion cell‐inner plexiform layer in people with drug‐resistant epilepsy

  2024cites this paper
• Glaucoma: what the neurologist needs to know

  2024cites this paper
• Utility of ganglion cells for the evaluation of anterior visual pathway pathology: a review

  2024cites this paper
• Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin

  2023cites this paper
• The Impact of Systemic Medications on Retinal Function.

  2023cites this paper
• Use of Visual Electrophysiology to Monitor Retinal and Optic Nerve Toxicity

  2022cites this paper
• Ocular examinations, findings, and toxicity in children taking vigabatrin

  2022cites this paper
• Visual field defects after vigabatrin treatment during infancy: retrospective population‐based study

  2021cites this paper
• Drugs Affecting the Central Nervous System

  2021cites this paper
• Investigation of the Effects of Anti-Epileptic Drug Treatment on Retinal Nerve Fiber Layer and Choroidal Thickness with Spectral Domain Optic Coherence Tomography

  2020cites this paper
• Reliability of Handheld Optical Coherence Tomography in Children Younger Than Three Years of Age Undergoing Vigabatrin Treatment for Childhood Epilepsy

  2020cites this paper
• the identification

  2019cites this paper
• The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin

  2019cites this paper
• The role of optical coherence tomography in therapeutics and conditions, which primarily have systemic manifestations: a narrative review

  2019cites this paper
• Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy

  2019cites this paper
• β-alanine supplementation induces taurine depletion and causes alterations of the retinal nerve fiber layer and axonal transport by retinal ganglion cells.

  2019cites this paper
• Reduction of retinal nerve fiber layer thickness in vigabatrin-exposed patients: A meta-analysis.

  2017cites this paper
• Ocular Manifestations of Neurologic Diseases

  2017cites this paper
• A Case Report of Occipital Lobe Epilepsy and Related Optical Coherence Tomography Findings

  2017cites this paper
• The use of optical coherence tomography in neuro-ophthalmology

  2017cites this paper
• Vigabatrin: Lessons Learned From the United States Experience

  2017cites this paper
• Optical coherence tomography to monitor vigabatrin toxicity in children.

  2016cites this paper
• Applications of Optical Coherence Tomography in Pediatric Clinical Neuroscience

  2015cites this paper
• Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex

  2015cites this paper
• Vigabatrin-associated visual field loss: past, present and future

  2014cites this paper
• Hypothesis-independent pathway analysis implicates GABA and Acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma

  2014cites this paper
• Association Between Electroretinogram-identified Vigabatrin Toxicity and Subsequent Visual Field Reduction

  2014cites this paper
• Some long-term outcomes of visual dysfunction arising from vigabatrin ocular toxicity

  2014cites this paper
• Modelling the Risk of Visual Field Loss Arising from Long-Term Exposure to the Antiepileptic Drug Vigabatrin: A Cross-Sectional Approach

  2013cites this paper
• Retinal Nerve Fiber Layer Defect Associated with Astrocytic Hamartoma in a Patient with Tuberous Sclerosis

  2013cites this paper